Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Ginseng, particularly Panax ginseng and Panax quinquefolius, has been investigated for its potential neuroprotective effects in Parkinson's Disease (PD). Several preclinical studies using cell cultures and rodent models of PD have shown that ginsenosides, the active components in ginseng, may exert antioxidant, anti-inflammatory, and anti-apoptotic effects. These mechanisms are relevant because oxidative stress and inflammation are implicated in the pathogenesis of PD. Some animal studies have demonstrated that ginseng extracts or isolated ginsenosides can reduce dopaminergic neuron loss and improve motor function in PD models. For example, ginsenoside Rg1 has been shown to attenuate dopaminergic neurodegeneration and improve behavioral outcomes in mice treated with neurotoxins used to mimic PD pathology.

However, clinical evidence in humans is extremely limited. Only a few small pilot studies and case reports have examined ginseng’s effects in PD patients, and the results are preliminary, with no robust randomized controlled trials conducted to date. Thus, while there is a scientific rationale and some positive findings from animal research, the evidence base is insufficient to recommend ginseng as a proven therapy for PD. Its use is primarily supported by preclinical science rather than tradition or strong clinical data.

More about Ginseng (unspecified)
More about Parkinson's Disease

Other ingredients used for Parkinson's Disease

Other health conditions supported by Ginseng (unspecified)

Products containing Ginseng (unspecified)